Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | -13.40% |
| Q2 2025 | -2.20% |
| Q1 2025 | 16.17% |
| Q4 2024 | -10.29% |
| Q3 2024 | -149.11% |
| Q2 2024 | 39.21% |
| Q1 2024 | 65.12% |
| Q4 2023 | -633.19% |
| Q3 2023 | -4802.66% |
| Q2 2023 | -102.63% |
| Q1 2023 | -19.46% |
| Q4 2022 | 86.23% |
| Q3 2022 | 712.82% |
| Q2 2022 | 58.84% |
| Q1 2022 | 62.36% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |